dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies.
dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies. Its business covers consulting, regulatory affairs & strategy, early clinical development, clinical science & medical affairs, clinical operations, biostatistics & programming, data management, drug safety & pharmacovigilance, quality assurance, and information solutions.dMed has set up offices in major cities, including Shanghai, Beijing, Wuhan, New York, Washington, San Francisco, and Brussels, and it employs around 600 professionals globally, among them 60% holds master above degree and 25% with more than 10 years working experiences.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 10, 2021 | Series C | $50M | 1 | — | — | Detail |
Dec 17, 2020 | Series C | $100M | 2 | — | — | Detail |
Oct 16, 2019 | Series B | $50M | 1 | — | — | Detail |
Dec 1, 2016 | Series A | $8M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Superstring Capital | — | Series C |
Kaiser Permanente | — | Series C |
Lilly Asia Ventures | — | Series C |
Tairui Investment | — | Series A |